Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) CFO Jack Anders sold 10,000 shares of Revolution Medicines stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $40.03, for a total value of $400,300.00. Following the completion of the transaction, the chief financial officer now directly […]
Revolution Medicines (NASDAQ:RVMD – Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.75) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link. Revolution […]
Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its target price upped by Oppenheimer from $43.00 to $45.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s price target points to a potential upside of 20.29% from the company’s current […]
Revolution Medicines (NASDAQ:RVMD – Get Free Report)‘s stock had its “buy” rating reissued by Needham & Company LLC in a research report issued to clients and investors on Monday, Benzinga reports. They presently have a $36.00 target price on the stock. Needham & Company LLC’s target price would indicate a potential upside of 9.12% from […]